Implantable Glucose Sensors. TheraSense agrees to keep Nipro ---------------------------- reasonably advised of TheraSense's progress with developing an implantable glucose sensor, and in the event TheraSense intends to make such sensor available for commercial sale in the Territory, TheraSense will provide Nipro an opportunity to offer its distribution services in the Territory for such sensor, which offer TheraSense is free to accept or reject without exception.
Appears in 5 contracts
Samples: International Distributor Agreement (Therasense Inc), International Distributor Agreement (Therasense Inc), International Distributor Agreement (Therasense Inc)